Nexalin Technology, Inc. (NXLIW) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
1776 Yorktown
Houston, TX 77056
United States of America (the)
Phone
713 660 1100
Website
Sector
Healthcare
Industry
Medical - Devices
Employees
6
First IPO Date
September 16, 2022
| Name | Title | Pay | Year Born |
| Mark White | President, Chief Executive Officer & Director | 598,000 | 1962 |
| David Owens | Chief Medical Officer, Member of Scientific Advisory Board & Director | 50,600 | 1962 |
| Carolyn Shelton | Executive Vice President of Clinical, Quality & Regulatory Affairs | 340,000 | 1963 |
| John Patrick Claude | Co-Founder and Director of Engineering & Development | 0 | N/A |
| Justin Van Fleet | Chief Financial Officer | 0 | 1981 |
Based in Houston, Texas, Nexalin Technology, Inc., founded in 2021, is a medical device firm dedicated to creating and advancing neurostimulation solutions. These products are designed to address mental health conditions within the United States and China. The company's primary offering, the Nexalin Device, is a licensed, non-invasive, and drug-free therapeutic option for managing anxiety and insomnia. This device functions by emitting a unique, patented frequency waveform that elicits a beneficial response from mid-brain structures implicated in various mental health disorders. Furthermore, Nexalin is currently developing its "Generation 2" medical device, which is undergoing clinical trials for potential treatment of opiate-related substance abuse, chronic pain, Alzheimer's disease, and dementia.